Nasdaq

Tactoset® Injectable Bone Substitute Now FDA Cleared for Hardware Augmentation

BEDFORD, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has ...
Seeking Alpha

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

Launches enhanced Tactoset cannulas, which improve targeting and ease of use in a variety of foot and ankle procedures BEDFORD, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (ANIK ...
Healio

Injectable bone substitute aids minimally invasive treatment for insufficiency fractures

Please provide your email address to receive an email when new articles are posted on . Bone voids, or bone marrow lesions, and other bone defects of the skeletal system are typically non-traumatic, ...